日本語 
Kura Oncology, Inc., and Kyowa Kirin Co., Ltd. announced Kura submitted a New Drug Application (NDA) for ziftomenib, a highly selective, once-daily, oral, investigational menin inhibitor, for the treatment of…
Latest News
AITRICS Launches Tokyo Office for Digital Health Growth
In a significant move for Japan's health-tech field, AITRICS, a medical AI…
ConcertAI Debuts TeraRecon AV for Smarter Med Imaging
ConcertAI rolled out TeraRecon AV, a new imaging platform built to cut…
Biz Hits and Craudia Debut Precise Medical Writing Service
Biz Hits has partnered with Craudia, the crowdsourcing platform run by Mflo,…
Emulate and FUJIFILM Unveil Brain-Chip R1
Emulate and FUJIFILM Cellular Dynamics have launched the Brain-Chip R1, a new…
Fujitsu Japan Uses GenAI to Cut Discharge Summary Time
At Nagoya Medical Center, the deployment of generative AI for the creation…
Konica Minolta OQL Introduces ‘miramos’ AI Shift Creator
Konica Minolta QOL Solutions, Inc. will begin offering "miramos," an AI-powered automatic…
Numab and Kaken Partner to Develop NM81 for IBD
Numab Therapeutics and Kaken Pharmaceutical have formed a partnership to develop NM81,…
BostonGene partners with Kyoto University on AI drug R&D
BostonGene and the University of Kyoto have come together to get more…
Latest Article
English